Kiwi Biosciences

Patent-pending enzymes to break down common dietary triggers

Jobs at Kiwi Biosciences

No jobs at Kiwi Biosciences are currently posted on the YC platform.

Why you should join Kiwi Biosciences

Kiwi Biosciences allows the 15% of the population suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without feeling like their intestines will explode. We develop novel patent-pending enzymes that break down common digestive triggers (starting with the FODMAP family of fermentable carbohydrates). Our first product FODZYME is a dietary supplement that enables folks to comfortably eat garlic, onion, wheat, and much more. Living with IBS isn't just a medical issue because not being able to eat the foods you love severely impacts quality of life. That's why for our customers, the product is magical. We launched FODZYME in 2021 and now serve tens of thousands of customers across the globe. Harvard-trained founders Anjie and David know firsthand how much the underserved IBS community needs this product: Anjie as a patient who developed FODZYME to solve her own gut problems and David who previously sold an IBS digital health company. FODZYME's research has been presented at leading GI conferences and published in a peer-reviewed journal. Join us to make food painless for the millions of people out there who need FODZYME!

Kiwi Biosciences
Founded:2020
Team Size:10
Location:Boston
Founders
David Hachuel
David Hachuel
Founder
Anjie Liu
Anjie Liu
Founder